martes, 8 de enero de 2019

Sanofi to exit immuno-oncology collaboration with Regeneron - STAT

Sanofi to exit immuno-oncology collaboration with Regeneron - STAT

Cancer Briefing

STAT Plus: Sanofi to exit immuno-oncology collaboration with Regeneron

By KATE SHERIDAN


RUBY WALLAU FOR STAT
Sanofi and Regeneron agreed to wind down a partnership, launched in 2015, sooner than is strictly necessary.

No hay comentarios: